Hepatobiliary Surgery Practice Questions

Q: After laparoscopic cholecystectomy, if biopsy reveals in situ cancer of the gallbladder (Stage I), what is the appropriate management?

Follow up. **Explanation:** The management of gallbladder cancer (GBC) discovered incidentally after laparoscopic cholecystectomy depends entirely on the **T-stage** (depth of invasion). **Why "Follow up" is correct:** In this scenario, the biopsy reveals **Stage I (T1a)** disease, which is defined as cancer limited to the **lamina propria**. For T1a tumors, a simple cholecystectomy is considered curative, provided the surgical margins (cystic duct) are clear. Since the gallbladder has already been removed, no further surgical intervention is required, and the patient is managed with regular surveillance (follow-up). **Why the other options are wrong:** * **B. Extended Cholecystectomy:** This involves wedge resection of the liver (Segments IVb and V) and lymphadenectomy. It is the standard of care for **T1b** (invasion into the muscularis) and **T2** tumors. It is "over-treatment" for T1a/In-situ disease. * **C. Excision of all port sites:** Routine port-site excision was previously practiced to prevent recurrence but is no longer recommended. Studies show it does not improve survival or decrease peritoneal recurrence. * **D. Radiotherapy:** Adjuvant therapy (Chemo-radiation) is generally reserved for locally advanced disease (T3, T4) or node-positive cases, not for early-stage in-situ cancer. **NEET-PG High-Yield Pearls:** * **T1a (Lamina propria):** Simple Cholecystectomy is enough. * **T1b (Muscularis) & T2 (Perimuscular connective tissue):** Requires Radical/Extended Cholecystectomy. * **Incidental GBC:** Most common way GBC is diagnosed (found in 0.2–1% of routine cholecystectomies). * **Most common site of GBC:** Fundus (60%). * **Most common histology:** Adenocarcinoma.

Q: A patient operated for colonic carcinoma develops a solitary nodule in the liver. What is the treatment of choice?

Surgery. **Explanation:** The liver is the most common site for distant metastasis in colorectal cancer (CRC) due to portal venous drainage. In the case of a **solitary liver metastasis** (or even limited resectable lesions), **Surgery (Hepatic Resection)** is the treatment of choice because it offers the only potential for long-term survival and cure. * **Why Surgery is Correct:** Unlike many other cancers where liver metastasis signifies terminal stage IV disease, colorectal liver metastases (CRLM) are unique. If the primary tumor is controlled and the liver lesion is resectable with adequate future liver remnant (FLR), surgery can achieve a 5-year survival rate of 30-50%. * **Why Other Options are Incorrect:** * **Radiation:** The liver has low tolerance for whole-organ radiation (risk of radiation-induced liver disease). While SBRT is an option for non-surgical candidates, it is not the "treatment of choice" for a fit patient with a resectable solitary nodule. * **Chemotherapy:** While often used as neoadjuvant or adjuvant therapy, chemotherapy alone is palliative and cannot achieve the curative rates offered by surgical resection. * **Conservative Treatment:** This is inappropriate for a potentially curable stage of metastatic disease. **Clinical Pearls for NEET-PG:** * **Resectability Criteria:** Based on whether the tumor can be completely removed (R0 resection) while leaving at least 25-30% of healthy liver tissue. * **Carcinoembryonic Antigen (CEA):** The most important tumor marker for monitoring recurrence in post-op colonic carcinoma patients. * **Synchronous vs. Metachronous:** If the liver nodule is found at the same time as the primary, it is "synchronous"; if found later, it is "metachronous." Surgery remains the gold standard for both if resectable.

Q: Which of the following is a tumor marker for hepatocellular carcinoma (HCC)?

Alpha-fetoprotein (AFP). **Explanation:** **Alpha-fetoprotein (AFP)** is the most widely used and established serum tumor marker for **Hepatocellular Carcinoma (HCC)**. It is a glycoprotein normally produced by the fetal yolk sac and liver. In adults, pathological elevation (typically >400 ng/mL) in the setting of chronic liver disease or cirrhosis is highly suggestive of HCC. However, it is important to note that AFP can also be elevated in germ cell tumors (yolk sac tumors) and during liver regeneration (chronic hepatitis). **Analysis of Options:** * **Alpha-fucosidase (AFU):** While AFU is a lysosomal enzyme that can be elevated in HCC patients, it is considered an *adjunct* marker rather than the primary diagnostic standard. It lacks the specificity and widespread clinical validation of AFP. * **Des-gamma-carboxyprothrombin (DCP/PIVKA-II):** This is an abnormal prothrombin molecule produced by HCC cells. While it is a highly specific marker for HCC and often used in combination with AFP to increase sensitivity, it is not the "classic" or primary answer expected in standard examinations unless specified as a complementary marker. * **CA 19-9:** This is the primary tumor marker for **Cholangiocarcinoma** and pancreatic adenocarcinoma. It is not specific for HCC. **High-Yield Clinical Pearls for NEET-PG:** * **Screening Protocol:** For high-risk patients (cirrhotics), the standard screening involves **USG Abdomen + Serum AFP** every 6 months. * **Diagnostic Threshold:** An AFP level >400 ng/mL in a patient with a hypervascular liver mass on Triphasic CT is often diagnostic. * **Fibrolamellar Variant:** This specific subtype of HCC (seen in young non-cirrhotics) typically has **normal AFP levels** but elevated Neurotensin. * **Other Markers:** Glypican-3 (GPC3) is a newer immunohistochemical marker used to differentiate HCC from benign nodules.

Q: What is the most common cause of biliary stricture?

Trauma. **Explanation:** The most common cause of biliary stricture is **iatrogenic trauma**, specifically injuries occurring during surgical procedures. **1. Why Trauma is Correct:** Approximately **80% of all benign biliary strictures** result from operative trauma. The most frequent culprit is **laparoscopic cholecystectomy**, where the common bile duct (CBD) may be inadvertently clipped, ligated, or transected due to anatomical variations or inflammation. Other traumatic causes include injuries during gastric resections, pancreatic surgeries, or liver transplantations. Ischemic injury to the bile duct (which relies on a tenuous blood supply at the 3 and 9 o'clock positions) also leads to post-surgical fibrosis and stricture formation. **2. Why Other Options are Incorrect:** * **Common bile duct stone:** While stones cause biliary *obstruction*, they rarely cause a permanent fibrous *stricture* unless they lead to chronic recurrent cholangitis or Mirizzi syndrome. * **Asiatic cholangitis (Recurrent Pyogenic Cholangitis):** This is a common cause of strictures in specific geographic regions (Southeast Asia) due to parasitic infections (e.g., *Clonorchis sinensis*), but it is not the most common cause globally or in general surgical practice. * **Congenital anomaly:** Conditions like biliary atresia or choledochal cysts cause neonatal or pediatric biliary issues but are far less common than acquired traumatic strictures in the general population. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Investigation:** MRCP (Magnetic Resonance Cholangiopancreatography) is the initial investigation of choice to define the anatomy. * **Management:** Minor leaks/strictures may be managed via ERCP with stenting. Major transections usually require a **Roux-en-Y Hepaticojejunostomy**. * **Bismuth Classification:** Used to grade the level of biliary stricture based on the distance from the hilar confluence.

Q: Surgical treatment by PAIR is indicated in which of the following conditions?

Hydatid disease. **Explanation:** **PAIR (Puncture, Aspiration, Injection, Re-aspiration)** is a minimally invasive percutaneous treatment modality specifically indicated for **Hydatid disease** (Cystic Echinococcosis) caused by *Echinococcus granulosus*. **Why Hydatid Disease is the Correct Answer:** The procedure involves: 1. **Puncture:** Ultrasound/CT-guided needle entry into the cyst. 2. **Aspiration:** Removal of cyst fluid to reduce pressure. 3. **Injection:** Introduction of a scolicidal agent (e.g., 95% ethanol or 20% hypertonic saline) for at least 20-30 minutes to kill the germinal layer and daughter cysts. 4. **Re-aspiration:** Removal of the scolicidal agent and debris. It is indicated for WHO stage CE1 and CE3a cysts (>5 cm) and in patients who are poor surgical candidates. **Why Other Options are Incorrect:** * **Amoebic Liver Abscess:** Treatment is primarily medical (Metronidazole). Aspiration is only indicated if the abscess is large (>10 cm), at risk of rupture, or involves the left lobe. * **Hepatocellular Carcinoma:** Managed via surgical resection, liver transplant, or locoregional therapies like TACE (Transarterial Chemoembolization) or RFA (Radiofrequency Ablation), not PAIR. * **Caroli’s Disease:** This is a congenital malformation of intrahepatic bile ducts. Management involves biliary drainage, ursodeoxycholic acid, or liver transplantation in cases of cirrhosis or malignancy. **NEET-PG High-Yield Pearls:** * **Contraindications for PAIR:** Superficial cysts (risk of rupture/peritonitis), inactive/calcified cysts (CE4/CE5), and cysts communicating with the biliary tree. * **Pre-procedure:** Patients must be started on **Albendazole** (10-15 mg/kg/day) at least 4 days before and continued for 1-3 months after PAIR to prevent secondary hydatidosis from accidental spillage. * **Gharbi Classification:** Used to stage hydatid cysts; PAIR is most effective for Type I (pure fluid) and Type II (fluid with split membranes).

Q: Sphincterectomy of the sphincter of Oddi is performed at which position?

11 O'clock position. ### Explanation The correct answer is **D. 11 O'clock position**. **1. Why 11 O'clock is Correct:** Endoscopic Sphincterotomy (EST) is performed during an ERCP (Endoscopic Retrograde Cholangiopancreatography) to facilitate stone extraction or stent placement. The common bile duct (CBD) typically enters the duodenum from a superior and slightly lateral direction. When viewing the Major Duodenal Papilla (Ampulla of Vater) through a side-viewing endoscope, the CBD is anatomically oriented toward the **11 to 12 o'clock position**. Cutting in this direction ensures that the incision stays within the longitudinal axis of the CBD, providing the safest and most direct access to the biliary tree. **2. Why Other Options are Incorrect:** * **3 and 9 O'clock positions:** These positions are lateral. Cutting here increases the risk of significant **hemorrhage** because the pancreaticoduodenal arteries run laterally to the papilla. * **6 O'clock position:** This is the inferior aspect of the papilla. Cutting here significantly increases the risk of **duodenal perforation** (retroperitoneal) and injury to the pancreatic duct, which typically enters the papilla from a more medial/inferior orientation (around the 5 o'clock position). **3. Clinical Pearls for NEET-PG:** * **The "Safe Zone":** The incision is always made between 11 and 12 o'clock to avoid the pancreatic duct and major vessels. * **Most Common Complication:** While bleeding and perforation are risks, the most common complication of ERCP/Sphincterotomy is **Post-ERCP Pancreatitis (PEP)**. * **Anatomical Landmark:** The Major Duodenal Papilla is located in the **second part (descending)** of the duodenum on the posteromedial wall. * **Sphincter of Boyden:** This is the specific sphincter surrounding the CBD just before it joins the pancreatic duct.

Q: A patient with gallstone disease underwent laparoscopic cholecystectomy. The pathology report revealed Stage 1A adenocarcinoma. What is the recommended treatment approach?

Observation and follow-up. **Explanation:** The management of incidental gallbladder cancer (found after laparoscopic cholecystectomy) is determined strictly by the **T-stage** (depth of invasion). **1. Why "Observation and follow-up" is correct:** Stage 1A corresponds to **T1a** disease, where the tumor is limited to the **lamina propria** only. At this stage, the lymph node involvement rate is extremely low (<2.5%), and the 5-year survival rate after a simple cholecystectomy is nearly 100%. Therefore, a simple cholecystectomy (which the patient has already undergone) is considered definitive treatment. No further surgical intervention or adjuvant therapy is required. **2. Why the other options are incorrect:** * **A. Extended cholecystectomy:** This involves wedge resection of the liver bed (Segments IVb and V) and regional lymphadenectomy. It is the standard of care for **T1b** (invasion into the muscularis) and **T2** tumors, but it provides no survival benefit for T1a. * **B. Chemotherapy:** Adjuvant chemotherapy is generally reserved for higher stages (T2 or node-positive disease) and is not indicated for early Stage 1A. * **D. Extended right hepatectomy:** This aggressive surgery is rarely indicated unless there is extensive local invasion into the right portal pedicle or multiple segments of the liver (usually T3/T4), which is not the case in Stage 1A. **Clinical Pearls for NEET-PG:** * **T1a:** Simple Cholecystectomy is enough. * **T1b, T2, T3:** Radical/Extended Cholecystectomy is required. * **Port-site excision:** Previously recommended, but current guidelines state it does not improve survival and is no longer routine. * **Most common histological type:** Adenocarcinoma. * **Most common site of metastasis:** Liver.

Question 1

An otherwise normal female presents with symptoms of flatulent dyspepsia. She was started on proton pump inhibitors, which controlled her symptoms. What is the next step in the management of this condition?

Accepted Answer

Wait and watch

Answer

Immediate laparoscopic cholecystectomy

Answer

Laparotomy after 1 or 2 months

Answer

Endoscopic retrograde cholangiopancreatography

Question 2

After laparoscopic cholecystectomy, if biopsy reveals in situ cancer of the gallbladder (Stage I), what is the appropriate management?

Accepted Answer

Follow up

Answer

Extended cholecystectomy

Answer

Excision of all port sites

Answer

Radiotherapy

Question 3

A patient operated for colonic carcinoma develops a solitary nodule in the liver. What is the treatment of choice?

Accepted Answer

Surgery

Answer

Radiation

Answer

Chemotherapy

Answer

Conservative treatment

Question 4

Which of the following is a tumor marker for hepatocellular carcinoma (HCC)?

Accepted Answer

Alpha-fetoprotein (AFP)

Answer

Alpha fucosidases

Answer

Des-gamma-carboxyprothrombin (DCGP)

Answer

Carbohydrate antigen 19-9 (CA 19-9)

Question 5

What is the most common cause of biliary stricture?

Accepted Answer

Trauma

Answer

Common bile duct stone

Answer

Asiatic cholangitis

Answer

Congenital anomaly

Question 6

Surgical treatment by PAIR is indicated in which of the following conditions?

Accepted Answer

Hydatid disease

Answer

Amoebic liver abscess

Answer

Hepatocellular carcinoma

Answer

Caroli's disease

Question 7

A critically ill patient recovering from surgery develops right upper quadrant pain. What is the probable diagnosis?

Accepted Answer

Acalculous cholecystitis

Answer

Calculous cholecystitis

Answer

Empyema of the gallbladder

Answer

Porcelain gallbladder

Question 8

Treatment of choledocholithiasis includes

Accepted Answer

Endoscopic papillotomy

Answer

ERCP

Answer

Ursodeoxycholic acid

Answer

Hepatojejunostomy

Question 9

Sphincterectomy of the sphincter of Oddi is performed at which position?

Accepted Answer

11 O'clock position

Answer

3 O'clock position

Answer

6 O'clock position

Answer

9 O'clock position

Question 10

A patient with gallstone disease underwent laparoscopic cholecystectomy. The pathology report revealed Stage 1A adenocarcinoma. What is the recommended treatment approach?

Accepted Answer

Observation and follow-up

Answer

Extended cholecystectomy

Answer

Chemotherapy

Answer

Extended cholecystectomy and extended right hepatectomy

Hepatobiliary Surgery — MCQs

Hepatobiliary Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?